Koyfin Home > Directory > Health Care > Aeglea Biothera > Net Debt / (EBITDA-CAPEX)

Aeglea Biothera Net Debt / (EBITDA-CAPEX) Chart (AGLE)

Aeglea Biothera annual/quarterly Net Debt / (EBITDA-CAPEX) from 2014 to 2020.
  • Aeglea Biothera Net Debt / (EBITDA-CAPEX) for the quarter ending June 06, 2020 was $2m a 43.95% increase of 1m year over year
  • Aeglea Biothera Net Debt / (EBITDA-CAPEX) for the last 12 months ending June 06, 2020 was $2m a 35.03% increase of 1m year over year
  • Aeglea Biothera Annual Net Debt / (EBITDA-CAPEX) for 2019 was $1m a -95.91% decrease of -1m from 2018
  • Aeglea Biothera Annual Net Debt / (EBITDA-CAPEX) for 2018 was $2m a -9.73% decrease of 0m from 2017
  • Aeglea Biothera Annual Net Debt / (EBITDA-CAPEX) for 2017 was $2m a -61.05% decrease of -1m from 2016
Other Ratios Metrics:
  • Aeglea Biothera Other Liabilities for the quarter ending December 12, 2018 was $0m a -40.28% decrease of 0m year over year
View Chart On Koyfin

Quarterly AGLE Net Debt / (EBITDA-CAPEX) Data

06/2020$2m
03/2020$1m
12/2019$1m
09/2019$1m
06/2019$1m
03/2019$2m
12/2018$1m
09/2018$1m
06/2018$2m
03/2018$1m

Annual AGLE Net Debt / (EBITDA-CAPEX) Data

2019$1m
2018$2m
2017$2m
2016$3m
2015$3m
2014$0m